Cell & Gene Therapy (CGT) Regulation
Regulatory expectations for vector design in gene therapy development
Regulatory Expectations for Vector Design in Gene Therapy Development The use of gene therapy vectors for treating various conditions has garnered significant attention in the biomedical field. However, effective compliance with regulatory requirements, particularly those from the U.S. Food and Drug Administration (FDA), is essential to ensure safe and effective therapeutic products. This tutorial aims to provide a comprehensive overview of the regulatory expectations regarding vector design, with a focus on viral shedding, biodistribution, and other relevant aspects. Following this guide will help regulatory, CMC, clinical, and QA leaders efficiently navigate the complexities of gene therapy product development. Understanding Gene…